General News

A confirmed Nipah virus outbreak has been reported in West Bengal, India, with five cases identified as of late January 2026. Health authorities have implemented quarantine, contact tracing, and enhanced surveillance to contain further spread.

Nipah virus (NiV) is a highly pathogenic zoonotic virus with a high fatality rate (40–75%) and the potential for human-to-human transmission.
Early and accurate molecular testing is critical for effective outbreak response.

Tianlong provides reliable molecular diagnostic solutions to support rapid Nipah virus detection and laboratory preparedness.

Tianlong Molecular Solutions for Nipah Virus Detection

• Nipah Virus Nucleic Acid Detection Kit (Fluorescence PCR Method)
  For qualitative detection of NiV nucleic acid in oropharyngeal and nasopharyngeal swabs, blood, and cerebrospinal fluid, ensuring accurate and reliable results.

• Platform: Panall 8000 All-in-One System
  Sample-in, result-out automation integrating nucleic acid extraction and real-time PCR.
  8-sample throughput with results in ~2 hours, ideal for rapid response and frontline laboratories.

• Platform: Modular Solution 

  A modular magnetic-bead extraction and real-time PCR workflow, configurable to different throughput needs. 

  Delivers ~1-hour turnaround, supports up to 96 samples per run.

Faster detection. Reliable results. Better outbreak preparedness.